Skip Navigation
Search Menu
Find a Doctor

 

Photo of Dr. Sophie Lanzkron

Sophie Miriam Lanzkron, M.D., M.H.S.

Associate Professor of Medicine

Female

Appointment Phone

410-955-3142

Main Location

The Johns Hopkins Hospital

Out-of-State & International Patients +
Out of State Patients

Call 410-464-6641 (8a.m. to 6p.m., EST, Mon-Fri)

Learn more about our out-of-state patient services »

International Patients

Call +1-410-502-7683 (7a.m. to 6p.m., EST, Mon-Fri)

Learn more about our international patient services »

Titles

  • Associate Professor of Medicine
  • Associate Professor of Oncology

Centers & Institutes

Departments

Locations

The Johns Hopkins Hospital

Appointment Phone: 410-955-3142

600 N. Wolfe Street
Sheikh Zayed Tower
Baltimore, MD 21287 map

Expertise

Hematology, Sickle Cell Disease

Research Interests

sickle cell disease

    Additional Information

  • Education +

    Degrees

    • Albert Einstein College of Medicine of Yeshiva Univ / MD (1991)

    Residencies

    • University of Maryland Medical Center / General Internal Medicine (1994)

    Fellowships

    • Johns Hopkins University School of Medicine / Hematology (1997)

    Certifications

    • American Board of Internal Medicine / Hematology (1996, 2006)
    • American Board of Internal Medicine / Internal Medicine (1994, 2005)
  • Research & Publications +

    Research Summary

    Dr. Lanzkron's major clinical research involves the study of sickle cell disease. Her primary research interest is to understand the barriers to care for adults with sickle cell disease. In 1998 the FDA approved the use of hydroxyurea to treat patients with sickle cell disease. This approval was based on a large clinical trial centered at Johns Hopkins. The use of hydroxyurea was predicted to decrease hospitalizations and the costs of care for those with sickle cell disease. Dr. Lanzkron's research has shown that despite the approval of hydroxyurea, the costs of caring for patients with sickle cell disease has increases significantly over the last seven years. Research is ongoing to identify the factors that limit access to care for this population. The Sickle Cell Center for Adults at Johns Hopkins under Dr. Lanzkron's directions provides comprehensive care to adults.

    Clinical Trial Keywords: sickle

  • Academic Affiliations & Courses +
  • Activities & Honors +
  • Videos & Media +
Is This You? Edit Profile